TreeWAS – Variant ID: rs2566752

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T36-T50 Poisoning by drugs, medicaments and biological substances	0.130	0.870	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.129	0.871	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.127	0.873	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.124	0.876	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.123	0.877	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.117	0.883	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.116	0.884	0.000
T45.0 Antiallergic and antiemetic drugs	0.116	0.884	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.115	0.885	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.114	0.886	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.113	0.887	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.107	0.893	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.106	0.894	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.105	0.895	0.000
T46.1 Calcium-channel blockers	0.104	0.896	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.103	0.897	0.000
T42.4 Benzodiazepines	0.103	0.897	0.000
T43.6 Psychostimulants with abuse potential	0.102	0.898	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.102	0.898	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.099	0.901	0.000
T43.2 Other and unspecified antidepressants	0.098	0.902	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.097	0.903	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.096	0.903	0.000
T42.0 Hydantoin derivatives	0.096	0.904	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.094	0.906	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.093	0.906	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.093	0.907	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.093	0.907	0.000
T46.7 Peripheral vasodilators	0.093	0.907	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.093	0.907	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.093	0.907	0.000
T43.9 Psychotropic drug, unspecified	0.091	0.908	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.091	0.908	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.091	0.909	0.000
T45.2 Vitamins, not elsewhere classified	0.091	0.909	0.000
T45.5 Anticoagulants	0.091	0.909	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.090	0.910	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.089	0.911	0.000
T45.8 Other primarily systemic and haematological agents	0.089	0.911	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.089	0.911	0.000
T45.6 Fibrinolysis-affecting drugs	0.089	0.911	0.000
T45.4 Iron and its compounds	0.089	0.911	0.000
T45.3 Enzymes, not elsewhere classified	0.089	0.911	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.088	0.912	0.000
T42.3 Barbiturates	0.085	0.915	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.084	0.916	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.084	0.916	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.083	0.916	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.083	0.917	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.083	0.917	0.000
T47.7 Emetics	0.083	0.917	0.000
T47.6 Antidiarrhoeal drugs	0.083	0.917	0.000
T47.5 Digestants	0.083	0.917	0.000
T47.3 Saline and osmotic laxatives	0.083	0.917	0.000
T47.2 Stimulant laxatives	0.083	0.917	0.000
T47.0 Histamine H(2)-receptor antagonists	0.083	0.917	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.082	0.917	0.000
T42.2 Succinimides and oxazolidinediones	0.082	0.917	0.000
T48.5 Anti-common-cold drugs	0.082	0.918	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.081	0.919	0.000
T47.4 Other laxatives	0.080	0.920	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.079	0.921	0.000
T42.1 Iminostilbenes	0.077	0.923	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.076	0.924	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.076	0.924	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.076	0.924	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.076	0.924	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.076	0.924	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.076	0.924	0.000
T44.0 Anticholinesterase agents	0.076	0.924	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.075	0.925	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.074	0.926	0.000
T48.4 Expectorants	0.074	0.926	0.000
T48.3 Antitussives	0.074	0.926	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.074	0.926	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.074	0.926	0.000
T48.0 Oxytocic drugs	0.074	0.926	0.000
T36 Poisoning by systemic antibiotics	0.074	0.926	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.072	0.928	0.000
T49.9 Topical agent, unspecified	0.069	0.931	0.000
T49.8 Other topical agents	0.069	0.931	0.000
T49.7 Dental drugs, topically applied	0.069	0.931	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.069	0.931	0.000
T49.5 Ophthalmological drugs and preparations	0.069	0.931	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.069	0.931	0.000
T49.3 Emollients, demulcents and protectants	0.069	0.931	0.000
T49.2 Local astringents and local detergents	0.069	0.931	0.000
T49.1 Antipruritics	0.069	0.931	0.000
T38.1 Thyroid hormones and substitutes	0.069	0.931	0.000
T38.9 Other and unspecified hormone antagonists	0.068	0.932	0.000
T38.7 Androgens and anabolic congeners	0.068	0.932	0.000
T38.5 Other oestrogens and progestogens	0.068	0.932	0.000
T38.4 Oral contraceptives	0.068	0.932	0.000
T38.2 Antithyroid drugs	0.068	0.932	0.000
T38.0 Glucocorticoids and synthetic analogues	0.068	0.932	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.068	0.932	0.000
T41.5 Therapeutic gases	0.067	0.933	0.000
T41.4 Anaesthetic, unspecified	0.067	0.933	0.000
T41.3 Local anaesthetics	0.067	0.933	0.000
T41.2 Other and unspecified general anaesthetics	0.067	0.933	0.000
T41.1 Intravenous anaesthetics	0.067	0.933	0.000
T41.0 Inhaled anaesthetics	0.067	0.933	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.067	0.933	0.000
T37.5 Antiviral drugs	0.067	0.933	0.000
T37.4 Anthelminthics	0.067	0.933	0.000
T37.3 Other antiprotozoal drugs	0.067	0.933	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.067	0.933	0.000
T37.1 Antimycobacterial drugs	0.067	0.933	0.000
T37.0 Sulphonamides	0.067	0.933	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.066	0.934	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.064	0.936	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.064	0.936	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.064	0.936	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.063	0.937	0.000
T50.8 Diagnostic agents	0.061	0.939	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.061	0.939	0.000
C56 Malignant neoplasm of ovary	0.060	0.940	0.000
T50.7 Analeptics and opioid receptor antagonists	0.058	0.942	0.000
T50.5 Appetite depressants	0.058	0.942	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.058	0.942	0.000
T50.1 Loop [high-ceiling] diuretics	0.058	0.942	0.000
T50.0 Mineralocorticoids and their antagonists	0.058	0.942	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.058	0.942	0.000
T40.4 Other synthetic narcotics	0.057	0.943	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.056	0.944	0.000
T39.0 Salicylates	0.055	0.945	0.000
T50.4 Drugs affecting uric acid metabolism	0.054	0.946	0.000
T36.9 Systemic antibiotic, unspecified	0.053	0.947	0.000
T36.8 Other systemic antibiotics	0.053	0.947	0.000
T36.7 Antifungal antibiotics, systemically used	0.053	0.947	0.000
T36.6 Rifamycins	0.053	0.947	0.000
T36.5 Aminoglycosides	0.053	0.947	0.000
T36.4 Tetracyclines	0.053	0.947	0.000
T36.2 Chloramphenicol group	0.053	0.947	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.053	0.947	0.000
T36.3 Macrolides	0.051	0.949	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.049	0.951	0.000
T40.5 Cocaine	0.049	0.951	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.046	0.954	0.000
T40.8 Lysergide [LSD]	0.046	0.954	0.000
T40.7 Cannabis (derivatives)	0.046	0.954	0.000
T40.3 Methadone	0.046	0.954	0.000
T40.1 Heroin	0.046	0.954	0.000
T40.0 Opium	0.046	0.954	0.000
T39.4 Antirheumatics, not elsewhere classified	0.046	0.954	0.000
T39.2 Pyrazolone derivatives	0.046	0.954	0.000
Q21.1 Atrial septal defect	0.000	0.960	0.040
T50.9 Other and unspecified drugs, medicaments and biological substances	0.039	0.961	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.038	0.962	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.037	0.962	0.000
T36.0 Penicillins	0.037	0.963	0.000
Q21 Congenital malformations of cardiac septa	0.000	0.963	0.037
Q20-Q28 Congenital malformations of the circulatory system	0.000	0.966	0.034
C51-C58 Malignant neoplasms of female genital organs	0.034	0.966	0.000
Q23 Congenital malformations of aortic and mitral valves	0.000	0.968	0.032
Q24 Other congenital malformations of heart	0.000	0.969	0.031
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.031	0.969	0.000
Q23.0 Congenital stenosis of aortic valve	0.000	0.970	0.030
Q25 Congenital malformations of great arteries	0.000	0.970	0.030
C57 Malignant neoplasm of other and unspecified female genital organs	0.030	0.970	0.000
Q24.5 Malformation of coronary vessels	0.000	0.971	0.029
C53 Malignant neoplasm of cervix uteri	0.028	0.972	0.000
Q21.3 Tetralogy of Fallot	0.000	0.972	0.028
Q24.8 Other specified congenital malformations of heart	0.000	0.972	0.028
C55 Malignant neoplasm of uterus, part unspecified	0.028	0.972	0.000
Q21.0 Ventricular septal defect	0.000	0.973	0.027
Q21.8 Other congenital malformations of cardiac septa	0.000	0.973	0.027
Q21.4 Aortopulmonary septal defect	0.000	0.973	0.027
Q21.2 Atrioventricular septal defect	0.000	0.973	0.027
Q21.9 Congenital malformation of cardiac septum, unspecified	0.000	0.973	0.026
C57.9 Female genital organ, unspecified	0.026	0.973	0.000
Q27 Other congenital malformations of peripheral vascular system	0.000	0.974	0.026
Q23.1 Congenital insufficiency of aortic valve	0.000	0.974	0.026
Q26 Congenital malformations of great veins	0.000	0.975	0.025
Q20 Congenital malformations of cardiac chambers and connexions	0.000	0.975	0.025
C58 Malignant neoplasm of placenta	0.024	0.976	0.000
Q25.4 Other congenital malformations of aorta	0.000	0.976	0.024
C53.9 Cervix uteri, unspecified	0.024	0.976	0.000
C57.0 Fallopian tube	0.023	0.976	0.000
Q25.1 Coarctation of aorta	0.000	0.977	0.023
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.000	0.977	0.023
Q23.8 Other congenital malformations of aortic and mitral valves	0.000	0.977	0.023
Q23.4 Hypoplastic left heart syndrome	0.000	0.977	0.023
Q23.3 Congenital mitral insufficiency	0.000	0.977	0.023
Q23.2 Congenital mitral stenosis	0.000	0.977	0.023
Q25.0 Patent ductus arteriosus	0.000	0.977	0.023
Q25.6 Stenosis of pulmonary artery	0.000	0.977	0.023
Q24.4 Congenital subaortic stenosis	0.000	0.977	0.022
Q24.3 Pulmonary infundibular stenosis	0.000	0.977	0.022
Q24.2 Cor triatriatum	0.000	0.977	0.022
Q24.1 Levocardia	0.000	0.977	0.022
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.000	0.977	0.023
C53.0 Endocervix	0.022	0.978	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.000	0.978	0.022
C51 Malignant neoplasm of vulva	0.022	0.978	0.000
Q25.9 Congenital malformation of great arteries, unspecified	0.000	0.978	0.022
Q25.8 Other congenital malformations of great arteries	0.000	0.978	0.022
Q25.7 Other congenital malformations of pulmonary artery	0.000	0.978	0.022
Q25.5 Atresia of pulmonary artery	0.000	0.978	0.022
Q25.3 Stenosis of aorta	0.000	0.978	0.022
Q25.2 Atresia of aorta	0.000	0.978	0.022
C57.8 Overlapping lesion of female genital organs	0.022	0.978	0.000
C57.7 Other specified female genital organs	0.022	0.978	0.000
C57.4 Uterine adnexa, unspecified	0.022	0.978	0.000
C57.3 Parametrium	0.022	0.978	0.000
C57.2 Round ligament	0.022	0.978	0.000
C57.1 Broad ligament	0.022	0.978	0.000
Q24.0 Dextrocardia	0.000	0.978	0.021
T40.6 Other and unspecified narcotics	0.020	0.979	0.001
C53.8 Overlapping lesion of cervix uteri	0.021	0.979	0.000
C53.1 Exocervix	0.021	0.979	0.000
Q28 Other congenital malformations of circulatory system	0.000	0.980	0.020
Q24.6 Congenital heart block	0.000	0.980	0.020
Q27.8 Other specified congenital malformations of peripheral vascular system	0.000	0.980	0.020
Q27.4 Congenital phlebectasia	0.000	0.981	0.019
Q27.2 Other congenital malformations of renal artery	0.000	0.981	0.019
Q27.1 Congenital renal artery stenosis	0.000	0.981	0.019
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.000	0.981	0.019
T39.1 4-Aminophenol derivatives	0.019	0.981	0.000
C52 Malignant neoplasm of vagina	0.018	0.981	0.000
Q24.9 Congenital malformation of the heart, unspecified	0.000	0.982	0.018
Q20.9 Congenital malformation of cardiac chambers and connexions, unspecified	0.000	0.982	0.018
Q20.8 Other congenital malformations of cardiac chambers and connexions	0.000	0.982	0.018
Q20.6 Isomerism of atrial appendages	0.000	0.982	0.018
Q20.5 Discordant atrioventricular connexion	0.000	0.982	0.018
Q20.4 Double inlet ventricle	0.000	0.982	0.018
Q20.3 Discordant ventriculoarterial connexion	0.000	0.982	0.018
Q20.2 Double outlet left ventricle	0.000	0.982	0.018
Q20.1 Double outlet right ventricle	0.000	0.982	0.018
Q20.0 Common arterial trunk	0.000	0.982	0.018
Q26.9 Congenital malformation of great vein, unspecified	0.000	0.982	0.018
Q26.8 Other congenital malformations of great veins	0.000	0.982	0.018
Q26.6 Portal vein-hepatic artery fistula	0.000	0.982	0.018
Q26.5 Anomalous portal venous connexion	0.000	0.982	0.018
Q26.4 Anomalous pulmonary venous connexion, unspecified	0.000	0.982	0.018
Q26.3 Partial anomalous pulmonary venous connexion	0.000	0.982	0.018
Q26.2 Total anomalous pulmonary venous connexion	0.000	0.982	0.018
Q26.1 Persistent left superior vena cava	0.000	0.982	0.018
Q26.0 Congenital stenosis of vena cava	0.000	0.982	0.018
C54 Malignant neoplasm of corpus uteri	0.017	0.983	0.000
C51.0 Labium majus	0.016	0.984	0.000
Q22.9 Congenital malformation of tricuspid valve, unspecified	0.000	0.984	0.016
Q22.8 Other congenital malformations of tricuspid valve	0.000	0.984	0.016
Q22.6 Hypoplastic right heart syndrome	0.000	0.984	0.016
Q22.4 Congenital tricuspid stenosis	0.000	0.984	0.016
Q22.3 Other congenital malformations of pulmonary valve	0.000	0.984	0.016
Q22.2 Congenital pulmonary valve insufficiency	0.000	0.984	0.016
Q22.0 Pulmonary valve atresia	0.000	0.984	0.016
C51.8 Overlapping lesion of vulva	0.016	0.984	0.000
C51.2 Clitoris	0.016	0.984	0.000
C51.1 Labium minus	0.016	0.984	0.000
Q22.5 Ebstein's anomaly	0.000	0.985	0.015
Z51.3 Blood transfusion without reported diagnosis	0.000	0.985	0.015
Q28.9 Congenital malformation of circulatory system, unspecified	0.000	0.985	0.015
Q28.8 Other specified congenital malformations of circulatory system	0.000	0.985	0.015
Q28.3 Other malformations of cerebral vessels	0.000	0.985	0.015
Q28.1 Other malformations of precerebral vessels	0.000	0.985	0.015
Q22.1 Congenital pulmonary valve stenosis	0.000	0.985	0.014
Q27.3 Peripheral arteriovenous malformation	0.000	0.986	0.014
Q28.2 Arteriovenous malformation of cerebral vessels	0.000	0.987	0.013
Z45.2 Adjustment and management of vascular access device	0.000	0.987	0.013
C51.9 Vulva, unspecified	0.013	0.987	0.000
Q28.0 Arteriovenous malformation of precerebral vessels	0.000	0.987	0.012
C54.8 Overlapping lesion of corpus uteri	0.012	0.987	0.000
C54.3 Fundus uteri	0.012	0.987	0.000
C54.2 Myometrium	0.012	0.987	0.000
C54.0 Isthmus uteri	0.012	0.987	0.000
C71.3 Parietal lobe	0.012	0.988	0.000
C71 Malignant neoplasm of brain	0.012	0.988	0.000
C54.9 Corpus uteri, unspecified	0.011	0.989	0.000
C71.0 Cerebrum, except lobes and ventricles	0.011	0.989	0.000
T40.2 Other opioids	0.011	0.989	0.000
C71.8 Overlapping lesion of brain	0.011	0.989	0.000
C71.2 Temporal lobe	0.010	0.990	0.000
C71.5 Cerebral ventricle	0.009	0.991	0.000
M45.X9 Ankylosing spondylitis (Site unspecified)	0.000	0.991	0.009
C71.1 Frontal lobe	0.009	0.991	0.000
B25.9 Cytomegaloviral disease, unspecified	0.000	0.991	0.009
C71.7 Brain stem	0.009	0.991	0.000
C71.6 Cerebellum	0.009	0.991	0.000
C71.4 Occipital lobe	0.008	0.992	0.000
C71.9 Brain, unspecified	0.008	0.992	0.000
Z00.6 Examination for normal comparison and control in clinical research programme	0.008	0.992	0.000
C54.1 Endometrium	0.008	0.992	0.000
H00.1 Chalazion	0.000	0.993	0.007
B25 Cytomegaloviral disease	0.000	0.994	0.006
R59.0 Localised enlarged lymph nodes	0.000	0.995	0.005
V23.4 Driver injured in traffic accident	0.005	0.995	0.000
S22.30 Fracture of rib (closed)	0.000	0.995	0.005
S72.10 Pertrochanteric fracture (closed)	0.000	0.995	0.005
R22.4 Localised swelling, mass and lump, lower limb	0.005	0.995	0.000
B25.8 Other cytomegaloviral diseases	0.000	0.995	0.005
B25.2 Cytomegaloviral pancreatitis	0.000	0.995	0.004
B25.1 Cytomegaloviral hepatitis	0.000	0.995	0.004
B25.0 Cytomegaloviral pneumonitis	0.000	0.995	0.004
N28.8 Other specified disorders of kidney and ureter	0.005	0.995	0.000
M45 Ankylosing spondylitis	0.000	0.996	0.004
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.000	0.996	0.004
S52.10 Fracture of upper end of radius (closed)	0.000	0.996	0.004
Z45.0 Adjustment and management of cardiac pacemaker	0.000	0.996	0.004
X59.3 Sports and athletics area	0.000	0.996	0.004
H74.8 Other specified disorders of middle ear and mastoid	0.000	0.996	0.004
Z45 Adjustment and management of implanted device	0.000	0.996	0.004
B34.8 Other viral infections of unspecified site	0.000	0.996	0.004
M70.65 Trochanteric bursitis-Pelvic/Thigh	0.000	0.996	0.004
Z49.0 Preparatory care for dialysis	0.000	0.996	0.004
B34 Viral infection of unspecified site	0.000	0.996	0.004
X59.4 Street and highway	0.000	0.996	0.004
R09.0 Asphyxia	0.000	0.996	0.004
B25-B34 Other viral diseases	0.000	0.996	0.004
X59 Exposure to unspecified factor	0.000	0.996	0.004
I78.1 Naevus, nonneoplastic	0.004	0.996	0.000
Z45.9 Adjustment and management of unspecified implanted device	0.000	0.996	0.004
N89.5 Stricture and atresia of vagina	0.004	0.996	0.000
Z00.4 General psychiatric examination, not elsewhere classified	0.003	0.996	0.000
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M45.X7 Ankylosing spondylitis (Lumbosacral region)	0.000	0.997	0.003
M45.X5 Ankylosing spondylitis (Thoracolumbar region)	0.000	0.997	0.003
M45.X4 Ankylosing spondylitis (Thoracic region)	0.000	0.997	0.003
M45.X3 Ankylosing spondylitis (Cervicothoracic region)	0.000	0.997	0.003
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)	0.000	0.997	0.003
F60.9 Personality disorder, unspecified	0.003	0.997	0.000
S92.00 Fracture of calcaneus (closed)	0.000	0.997	0.003
S22.3 Fracture of rib	0.000	0.997	0.003
S32.50 Fracture of pubis (closed)	0.000	0.997	0.003
B34.4 Papovirus infection, unspecified	0.000	0.997	0.003
H44.9 Disorder of globe, unspecified	0.003	0.997	0.000
B34.3 Parvovirus infection, unspecified	0.000	0.997	0.003
B34.2 Coronavirus infection, unspecified	0.000	0.997	0.003
B34.1 Enterovirus infection, unspecified	0.000	0.997	0.003
B34.0 Adenovirus infection, unspecified	0.000	0.997	0.003
H44.2 Degenerative myopia	0.003	0.997	0.000
X59.2 School, other institution and public administrative area	0.000	0.997	0.003
Z00 General examination and investigation of persons without complaint or reported diagnosis	0.003	0.997	0.000
B34.9 Viral infection, unspecified	0.000	0.997	0.003
Z45.3 Adjustment and management of implanted hearing device	0.000	0.997	0.003
F60 Specific personality disorders	0.003	0.997	0.000
H44 Disorders of globe	0.003	0.997	0.000
H44.0 Purulent endophthalmitis	0.003	0.997	0.000
M45.X2 Ankylosing spondylitis (Cervical region)	0.000	0.997	0.003
F60.3 Emotionally unstable personality disorder	0.003	0.997	0.000
B30 Viral conjunctivitis	0.000	0.997	0.003
B26 Mumps	0.000	0.997	0.003
X59.9 Unspecified place	0.000	0.997	0.003
X59.8 Other specified place	0.000	0.997	0.003
X59.0 Home	0.000	0.997	0.003
X59.7 Farm	0.000	0.997	0.003
X59.6 Industrial and construction area	0.000	0.997	0.003
X59.5 Trade and service area	0.000	0.997	0.003
X59.1 Residential institution	0.000	0.997	0.003
S42.40 Fracture of lower end of humerus (closed)	0.000	0.997	0.003
B33 Other viral diseases, not elsewhere classified	0.000	0.997	0.003
C67.2 Lateral wall of bladder	0.000	0.997	0.003
I27.2 Other secondary pulmonary hypertension	0.000	0.997	0.003
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.003	0.997	0.000
G61.8 Other inflammatory polyneuropathies	0.003	0.997	0.000
M45.X6 Ankylosing spondylitis (Lumbar region)	0.000	0.997	0.002
S42.10 Fracture of scapula (closed)	0.000	0.997	0.003
F10.0 Acute intoxication	0.003	0.997	0.000
F60.8 Other specific personality disorders	0.003	0.997	0.000
F60.5 Anankastic personality disorder	0.003	0.997	0.000
F33.9 Recurrent depressive disorder, unspecified	0.003	0.997	0.000
S42.00 Fracture of clavicle (closed)	0.000	0.997	0.003
B27 Infectious mononucleosis	0.000	0.997	0.003
S22.31 Fracture of rib (open)	0.000	0.997	0.003
S52.1 Fracture of upper end of radius	0.000	0.997	0.003
G62.9 Polyneuropathy, unspecified	0.003	0.997	0.000
H74.4 Polyp of middle ear	0.000	0.997	0.003
R09.1 Pleurisy	0.000	0.997	0.003
H44.1 Other endophthalmitis	0.002	0.997	0.000
V23 Motorcycle rider injured in collision with car, pick-up truck or van	0.002	0.997	0.000
G70.0 Myasthenia gravis	0.000	0.997	0.003
Z00.8 Other general examinations	0.002	0.997	0.000
H74 Other disorders of middle ear and mastoid	0.000	0.997	0.003
F60.4 Histrionic personality disorder	0.002	0.998	0.000
F60.2 Dissocial personality disorder	0.002	0.998	0.000
F60.1 Schizoid personality disorder	0.002	0.998	0.000
N41.1 Chronic prostatitis	0.000	0.998	0.002
Z00.3 Examination for adolescent development state	0.002	0.998	0.000
Z00.2 Examination for period of rapid growth in childhood	0.002	0.998	0.000
Z00.1 Routine child health examination	0.002	0.998	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.000	0.998	0.002
H44.5 Degenerated conditions of globe	0.002	0.998	0.000
L05.9 Pilonidal cyst without abscess	0.002	0.998	0.000
F60.7 Dependent personality disorder	0.002	0.998	0.000
F60.6 Anxious [avoidant] personality disorder	0.002	0.998	0.000
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.002	0.998	0.000
H44.6 Retained (old) intraocular foreign body, magnetic	0.002	0.998	0.000
H44.3 Other degenerative disorders of globe	0.002	0.998	0.000
K35.0 Acute appendicitis with generalised peritonitis	0.002	0.998	0.000
Z13.9 Special screening examination, unspecified	0.000	0.998	0.002
S42.4 Fracture of lower end of humerus	0.000	0.998	0.002
H74.9 Disorder of middle ear and mastoid, unspecified	0.000	0.998	0.002
K10.8 Other specified diseases of jaws	0.002	0.998	0.000
B26.9 Mumps without complication	0.000	0.998	0.002
B26.8 Mumps with other complications	0.000	0.998	0.002
B26.3 Mumps pancreatitis	0.000	0.998	0.002
B26.2 Mumps encephalitis	0.000	0.998	0.002
B26.1 Mumps meningitis	0.000	0.998	0.002
B26.0 Mumps orchitis	0.000	0.998	0.002
B30.9 Viral conjunctivitis, unspecified	0.000	0.998	0.002
B30.8 Other viral conjunctivitis	0.000	0.998	0.002
B30.3 Acute epidemic haemorrhagic conjunctivitis (enteroviral)	0.000	0.998	0.002
B30.2 Viral pharyngoconjunctivitis	0.000	0.998	0.002
B30.1 Conjunctivitis due to adenovirus	0.000	0.998	0.002
B30.0 Keratoconjunctivitis due to adenovirus	0.000	0.998	0.002
S42.1 Fracture of scapula	0.000	0.998	0.002
F60.0 Paranoid personality disorder	0.002	0.998	0.000
H44.4 Hypotony of eye	0.002	0.998	0.000
S42.0 Fracture of clavicle	0.000	0.998	0.002
R59 Enlarged lymph nodes	0.000	0.998	0.002
X59.09 Exposure to unspecified factor causing fracture; Unspecified place;	0.000	0.998	0.002
X59.88 Exposure to unspecified factor; Other specified places ;While engaged in other specified activities	0.000	0.998	0.002
X59.99 Exposure to unspecified factor causing other and unspecified injury, Unspecified place	0.000	0.998	0.002
S22.00 Fracture of thoracic vertebra (closed)	0.000	0.998	0.002
H00 Hordeolum and chalazion	0.000	0.998	0.002
S72.1 Pertrochanteric fracture	0.000	0.998	0.002
F20.9 Schizophrenia, unspecified	0.000	0.998	0.002
S92.0 Fracture of calcaneus	0.000	0.998	0.002
Z37.2 Twins, both liveborn	0.002	0.998	0.000
B27.0 Gammaherpesviral mononucleosis	0.000	0.998	0.002
B33.4 Hantavirus (cardio-)pulmonary syndrome [HPS] [HCPS]	0.000	0.998	0.002
B33.3 Retrovirus infections, not elsewhere classified	0.000	0.998	0.002
B33.2 Viral carditis	0.000	0.998	0.002
B33.1 Ross River disease	0.000	0.998	0.002
B33.0 Epidemic myalgia	0.000	0.998	0.002
C67.1 Dome of bladder	0.000	0.998	0.002
G96.1 Disorders of meninges, not elsewhere classified	0.002	0.998	0.000
H60.1 Cellulitis of external ear	0.000	0.998	0.002
B27.8 Other infectious mononucleosis	0.000	0.998	0.002
B27.1 Cytomegaloviral mononucleosis	0.000	0.998	0.002
S52.11 Fracture of upper end of radius (open)	0.000	0.998	0.002
G71.3 Mitochondrial myopathy, not elsewhere classified	0.000	0.998	0.002
I27.0 Primary pulmonary hypertension	0.000	0.998	0.002
S22.0 Fracture of thoracic vertebra	0.000	0.998	0.002
N99.4 Postprocedural pelvic peritoneal adhesions	0.002	0.998	0.000
H60.9 Otitis externa, unspecified	0.000	0.998	0.002
G70 Myasthenia gravis and other myoneural disorders	0.000	0.998	0.002
M86.67 Other chronic osteomyelitis (Ankle and foot)	0.002	0.998	0.000
S52.30 Fracture of shaft of radius (closed)	0.000	0.998	0.002
V23.9 Unspecified motorcycle rider injured in traffic accident	0.002	0.998	0.000
V23.3 Person injured while boarding or alighting	0.002	0.998	0.000
V23.2 Unspecified motorcycle rider injured in nontraffic accident	0.002	0.998	0.000
V23.1 Passenger injured in nontraffic accident	0.002	0.998	0.000
V23.0 Driver injured in nontraffic accident	0.002	0.998	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.000	0.998	0.002
B33.8 Other specified viral diseases	0.000	0.998	0.002
C67.3 Anterior wall of bladder	0.000	0.998	0.002
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.002	0.998	0.000
S42 Fracture of shoulder and upper arm	0.000	0.998	0.002
D35.1 Parathyroid gland	0.000	0.998	0.002
H44.8 Other disorders of globe	0.002	0.998	0.000
H74.3 Other acquired abnormalities of ear ossicles	0.000	0.998	0.002
H74.2 Discontinuity and dislocation of ear ossicles	0.000	0.998	0.002
K09.0 Developmental odontogenic cysts	0.000	0.998	0.002
R59.1 Generalised enlarged lymph nodes	0.000	0.998	0.002
V23.5 Passenger injured in traffic accident	0.002	0.998	0.000
G61 Inflammatory polyneuropathy	0.002	0.998	0.000
S22 Fracture of rib(s), sternum and thoracic spine	0.000	0.998	0.002
F20.0 Paranoid schizophrenia	0.000	0.998	0.002
F40.2 Specific (isolated) phobias	0.000	0.998	0.002
S32.5 Fracture of pubis	0.000	0.998	0.002
Z45.1 Adjustment and management of infusion pump	0.000	0.998	0.002
M86.65 Other chronic osteomyelitis (Pelvic region and thigh)	0.002	0.998	0.000
G72.0 Drug-induced myopathy	0.000	0.998	0.002
N41.0 Acute prostatitis	0.000	0.998	0.002
C70 Malignant neoplasm of meninges	0.002	0.998	0.000
H60.5 Acute otitis externa, non-infective	0.000	0.998	0.002
M07.3 Other psoriatic arthropathies	0.000	0.998	0.002
S56.1 Injury of flexor muscle and tendon of other finger(s) at forearm level	0.000	0.998	0.002
H60 Otitis externa	0.000	0.998	0.002
S42.11 Fracture of scapula (open)	0.000	0.998	0.002
S42.41 Fracture of lower end of humerus (open)	0.000	0.998	0.002
H35.7 Separation of retinal layers	0.002	0.998	0.000
S42.9 Fracture of shoulder girdle, part unspecified	0.000	0.998	0.002
S42.01 Fracture of clavicle (open)	0.000	0.998	0.002
H74.1 Adhesive middle ear disease	0.000	0.998	0.002
L40.5 Arthropathic psoriasis	0.000	0.998	0.002
O14.9 Preeclampsia, unspecified	0.002	0.998	0.000
B15.9 Hepatitis A without hepatic coma	0.002	0.998	0.000
O14.0 Moderate preeclampsia	0.002	0.998	0.000
S72.11 Pertrochanteric fracture (open)	0.000	0.998	0.002
S92.01 Fracture of calcaneus (open)	0.000	0.998	0.002
F10.3 Withdrawal state	0.002	0.998	0.000
M86.6 Other chronic osteomyelitis	0.002	0.998	0.000
Z00.5 Examination of potential donor of organ and tissue	0.002	0.998	0.000
F20 Schizophrenia	0.000	0.998	0.002
G72.8 Other specified myopathies	0.000	0.998	0.002
Z89.4 Acquired absence of foot and ankle	0.002	0.998	0.000
S42.90 Fracture of shoulder girdle, part unspecified (closed)	0.000	0.998	0.002
M70.6 Trochanteric bursitis	0.000	0.998	0.002
N41.9 Inflammatory disease of prostate, unspecified	0.000	0.998	0.002
G71 Primary disorders of muscles	0.000	0.998	0.002
I27 Other pulmonary heart diseases	0.000	0.998	0.002
S42.8 Fracture of other parts of shoulder and upper arm	0.000	0.998	0.002
Z57.5 Occupational exposure to toxic agents in other industries	0.000	0.998	0.002
G72 Other myopathies	0.000	0.998	0.002
M86.66 Other chronic osteomyelitis (Lower leg)	0.002	0.998	0.000
R68.8 Other specified general symptoms and signs	0.002	0.998	0.000
C67 Malignant neoplasm of bladder	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations